Biodexa Pharmaceuticals Plc (BDRX) Earnings History
Net Loss14 years of earnings data (2012–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Biodexa Pharmaceuticals Plc (BDRX) Earnings Overview
As of June 23, 2026, Biodexa Pharmaceuticals Plc (BDRX) reported trailing twelve-month net income of -$12M, reflecting +100.0% year-over-year growth. The company earned $-53.57 per diluted share over the past four quarters.
Looking at the long-term picture, BDRX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2012.
Biodexa Pharmaceuticals Plc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SIGA ($20M net income, 24.6% margin), NUVB (-$146M net income, -325.3% margin), IMVT (-$506M net income), BDRX has comparable earnings metrics. Compare BDRX vs SIGA →
BDRX Earnings vs Peers
Earnings metrics vs comparable public companies
BDRX Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$6M | -9.0% | -$8M | $-60.00 | - | - |
| 2024 | -$6M | +19.1% | -$9M | $-999999.00 | - | - |
| 2023 | -$7M | +7.5% | -$8M | $-229000.00 | -1858.0% | -2103.4% |
| 2022 | -$8M | -40.2% | -$9M | $-999999.00 | -1095.3% | -1277.8% |
| 2021 | -$5M | +75.4% | -$7M | $-999999.00 | -944.6% | -1210.7% |
| 2020 | -$22M | -120.0% | -$23M | $-999999.00 | -6469.1% | -6717.2% |
| 2019 | -$10M | +2.7% | -$11M | $-999999.00 | -1496.3% | -1679.2% |
| 2018 | -$10M | +11.4% | -$12M | $-999999.00 | -535.0% | -609.6% |
| 2017 | -$12M | -90.0% | -$12M | $-999999.00 | -1183.5% | -1190.7% |
| 2016 | -$6M | +39.0% | -$10M | $-999999.00 | -465.7% | -729.6% |
| 2015 | -$10M | -14.5% | -$10M | $-999999.00 | -734.5% | -734.0% |
| 2014 | -$9M | -116.0% | -$8M | $-999999.00 | -5619.1% | -4914.0% |
| 2013 | -$4M | -2.3% | -$4M | $-999999.00 | -2778.2% | -3060.5% |
| 2012 | -$4M | - | -$4M | $-999999.00 | - | - |
Download Data
Export BDRX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BDRX — Frequently Asked Questions
Quick answers to the most common questions about buying BDRX stock.
What is BDRX earnings per share (EPS)?
BDRX trailing twelve-month (TTM) diluted EPS is $-53.57, reflecting +100.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is Biodexa Pharmaceuticals Plc's net income?
Biodexa Pharmaceuticals Plc (BDRX) trailing twelve-month net income is $-12M as of 2025. Earnings grew +100.0% year-over-year.
Is BDRX profitable?
BDRX is not currently profitable on a TTM basis, reporting a net loss of $-12M. Net margin is N/A. Investors should monitor for a return to profitability.
What is BDRX's earnings growth rate?
BDRX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are BDRX's profit margins?
Biodexa Pharmaceuticals Plc net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -63.4%.
Is BDRX growing earnings?
Yes, BDRX earnings are accelerating — EPS growth of +100.0% exceeds the 5-year CAGR of N/A. TTM net income reached $-12M. Earnings momentum is strengthening.
What was BDRX's best earnings year?
Biodexa Pharmaceuticals Plc's highest annual net income on record is $-4M, achieved in fiscal year 2012. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were BDRX's earnings last quarter?
BDRX's most recent reported quarter was Q4 2025. Net income was $-3M with diluted EPS of $0.00. For a full breakdown of all quarters, see the quarterly earnings table on this page.